The Association between Health System Development and the Burden of Cardiovascular Disease: An Analysis of WHO Country Profiles

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Liu, Yanmei ^a,b   Dalal, Koustuv ^c   Stollenwerk, Björn ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ÖREBRO UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; DISABILITY ADJUSTED LIFE YEAR; HEALTH CARE; HEALTH CARE CONCEPTS; HEALTH CARE COST; HEALTH CARE MANPOWER; HOSPITAL BED; MIDWIFE; OUT OF POCKET COST; PHARMACIST; PHYSICIAN;

CARDIOVASCULAR DISEASES; COST OF ILLNESS; DEVELOPING COUNTRIES; FEMALE; HEALTH EXPENDITURES; HEALTH MANPOWER; HEALTH RESOURCES; HUMANS; MALE; QUALITY-ADJUSTED LIFE YEARS; WORLD HEALTH ORGANIZATION;

EID: 84876325153     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061718     Document Type: Article

References (41)

1. World Health Organization (2000) The World Health Report 2000. Health Systems: Improving Performance. Geneva: World Health Organization.
2. Muldoon KA, Galway LP, Nakajima M, Kanters S, Hogg RS, et al. (2011) Health system determinants of infant, child and maternal mortality: A cross-sectional study of UN member countries. Global Health 7: 42.
3. World Health Organization (2007) Strengthening health systems to improve health outcomes. Geneva: World Health Organization.
4. Musgrove P, Zeramdini R, Carrin G, (2002) Basic patterns in national health expenditure. Bull World Health Organ 80: 134-142.
5. Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, et al. (2011) The global burden of cardiovascular disease. Eur J Cardiovasc Nurs 10 Suppl 2: S5-13.
6. Gaziano TA, (2008) Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart 94: 140-144.
7. Mbewu A, Mbanya J-C (2006) Cardiovascular disease. In: Jamison DT, Feachem RG, Makgoba MW, et al., editors. Disease and Mortality in Sub-Saharan Africa. 2nd ed. Washington (DC): World Bank.
8. Gaziano TA, (2007) Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood) 26: 13-24.
9. Maher D, Smeeth L, Sekajugo J, (2010) Health transition in Africa: practical policy proposals for primary care. Bull World Health Organ 88: 943-948.
10. Shenoy AU, Aljutaili M, Stollenwerk B, (2012) Limited Economic Evidence of Carotid Artery Stenosis Diagnosis and Treatment: A Systematic Review. Eur J Vasc Endovasc Surg 44: 505-513.
11. Stollenwerk B, Gerber A, Lauterbach KW, Siebert U, (2009) The German Coronary Artery Disease Risk Screening Model: development, validation, and application of a decision-analytic model for coronary artery disease prevention with statins. Med Decis Making 29: 619-633.
12. Zechmeister I, Ara R, Ward S, Stollenwerk B, (2012) Have statins met our expectations? A comparison of expected health gains from statins with epidemiological trends in Austria. J Public Health (Springer) 20: 31-39.
13. Stock S, Schmidt H, Buscher G, Gerber A, Drabik A, et al. (2010) Financial incentives in the German Statutory Health Insurance: new findings, new questions. Health Policy 96: 51-56.
14. Zindel S, Stock S, Muller D, Stollenwerk B, (2012) A Multi-Perspective Cost-Effectiveness Analysis Comparing Rivaroxaban with Enoxaparin Sodium for Thromboprophylaxis after Total Hip and Knee Replacement in the German Healthcare Setting. BMC Health Serv Res 12: 192.
15. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K, (2007) The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370: 1929-1938.
16. Murray CJ, (1994) Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 72: 429-445.
17. Murray CJ, Lopez AD, (1994) Quantifying disability: data, methods and results. Bull World Health Organ 72: 481-494.
18. Mathers CD, Lopez AD, Murray CJL (2006) The burden of disease and mortality by condition: data, methods and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Murray CJL, Jamison DT, editors. Global burden of disease and risk factors. New York: Oxford University Press. pp. 45-240.
19. Hunger M, Sabariego C, Stollenwerk B, Cieza A, Leidl R, (2011) Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res 21: 1205-1216.
20. Stollenwerk B, Gandjour A, Lungen M, Siebert U, (2013) Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation. Eur J Health Econ [online first].
21. World Health Organization (2012) WHO Statistical Information System (WHOSIS): age-standardized mortality rates (per 100 000 population) by cause. Geneva: World Health Organization.
22. World Health Organization (2011) Global health observatory data repository. Geneva: World Health Organization.
23. World Health Organization (2011) Indicator and Measurement Registry version 1.6.0. Geneva: World Health Organization.
24. Dobson AJ (2002) An introduction to generalized linear models. London: Chapman & Hall/CRC.
25. Wood SN (2006) Generalized Additive Models: an introduction with R. London: Chapman & Hall/CRC.
26. Holm S, (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6: 65-70.
27. R Development Core Team (2010) R: A language and environment for statistical computing. Vienna, Austria:R Foundation for Statistical Computing.
28. Elola J, Daponte A, Navarro V, (1995) Health indicators and the organization of health care systems in western Europe. Am J Public Health 85: 1397-1401.
29. Bardaji A, Sigauque B, Sanz S, Maixenchs M, Ordi J, et al. (2011) Impact of malaria at the end of pregnancy on infant mortality and morbidity. J Infect Dis 203: 691-699.
30. De Longueville F, Hountondji YC, Henry S, Ozer P, (2010) What do we know about effects of desert dust on air quality and human health in West Africa compared to other regions? Sci Total Environ 409: 1-8.
31. Sauer MT, Wagner MB, (2003) Fatal traffic accidents and their association with the infant mortality rate and adolescence. Cad Saude Publica 19: 1519-1526.
32. Starfield B, Shi L, Macinko J, (2005) Contribution of primary care to health systems and health. The Milbank Quarterly 83: 457-502.
33. Alexander GC, Casalino LP, Tseng CW, McFadden D, Meltzer DO, (2004) Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med 19: 856-860.
34. Falkingham J, (2004) Poverty, out-of-pocket payments and access to health care: evidence from Tajikistan. Soc Sci Med 58: 247-258.
35. Steinman MA, Sands LP, Covinsky KE, (2001) Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 16: 793-799.
36. Robey B, (1993) The birth rate decline in developing countries. Outlook Agric 22: 221-224.
37. Ambrose JA, Barua RS, (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43: 1731-1737.
38. Marmot M, Brunner E, (1991) Alcohol and cardiovascular disease: the status of the U shaped curve. BMJ 303: 565-568.
39. Murray RP, Connett JE, Tyas SL, Bond R, Ekuma O, et al. (2002) Alcohol volume, drinking pattern, and cardiovascular disease morbidity and mortality: is there a U-shaped function? Am J Epidemiol 155: 242-248.
40. Gruber EV, Stock S, Stollenwerk B, (2012) Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data. PLoS One 7: e51312.
41. Green SB, (1991) How many subjects does it take to do a regression analysis. Multivariate Behav Res 26: 499-510.